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Tobacco mosaic virus (TMV) is a particularly suitable object for studies on the
physical and chemical structure of viruses and on the mutagenic effects of various
treatments. The virus may be obtained in gram amounts and readily purified. Its
biological activity may be assayed quantitatively by measuring the number of ne-
crotic lesions which it produces on the leaves of suitable tobacco plants; mutants may
be detected by noting the characteristics of individual lesions, or the visible expres-
sion of symptoms in systemically infected plants. The internal structure of TMV has
been determined largely by X-ray analysis, aided and confirmed by electron micro-
scopy. The particle is a nucleoprotein containing about 5 per cent ribonucleic acid
(RNA). The protein component consists of 2200 sub-units, presumably chemically
identical, arranged in a helical manner to produce the rod-like structure of the virus.
Embedded within the protein helix is the RNA, consisting of 6600 nucleotides and
appearing to follow the pitch of the helix of the protein sub-units. Each protein sub-
unit, of molecular weight 17,500, consists of one chain of 158 amino acids, the com-
plete sequence of which has been independently determined in Tubingen and in
Berkeley. There appear to be no simple regularities in the sequential arrangement
of the amino acids. Protein sub-units alone (without nucleic acid) are capable of a
characteristic reaggregation, under suitable conditions of solution, to form rods
which are indistinguishable from those of the intact virus except for a non-uni-
formity of length.
The RNA component of TMV can be isolated from the virus as a single poly-
meric entity with a molecular weight of about 2 million. The kinetics of the action
of ribonuclease indicate that it exists as a single polynucleotide strand, in contrast
to the double-stnnd ctharacter of DNA. In solution the RNA polymer shows evi-
dence of coiling and folding, and this tertiary structure may be reversibly affected by
changes of temperature and of ionic strength of the solvent. It appears, then, that
the RNA of TMV is a molecule consisting of one linear sequence of 6600 nucleo-
tides, a number far too great to allow a sequential determination of nucleotide ar-
rangement to be made at this time. Some information about sequence is being
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gleaned from the products of degradation obtained by specific enzymes. Such degra-
dation fragments have been chromatographed two-dimensionally and show a highly
complex pattern which defies any attempt at sequential analysis. However, the pat-
tern of RNA from TMV is characteristic of this material and is easily distinguishable
from that of the RNA of the host cell and of other RNA viruses.
The function of the nucleic acid is now generally accepted as being primarily a
genetic one. It has been shown, both in Tiibingen and in Berkeley, that when RNA
is carefully isolated from the virus by any one of several methods it will produce
the same symptoms of infection as will the intact, native virus. The level of infectiv-
ity, however, is much lower than that of the virus from which it is isolated. It has
been shown by meticulous assessment of the amount of protein material associated
with the purified RNA that contamination by protein cannot be the source of the
infectivity of the RNA. Indeed the infectivity of isolated RNA is not reduced when
the level of protein contamination is less than an amount sufficient to provide a single
protein sub-unit per RNA molecule. Another bit of evidence for the absence of
appreciable contamiant protein is the fact that the purified RNA is not in any way
inactivated by anti-serum against the viral protein.
Since the RNA from TMV may be isolated in highly purified form and is infec-
tive, it serves as a particularly suitable object for studying the structural basis of
the transfer of genetic information. It has been found, in Tiibingen and elsewhere,
that infection may be initiated by the RNA molecule only in its intact form. Smaller
fragments which can be isolated to some extent by centrifugation are inactive.
Similarly, treatment by ribonuclease to the extent of causing only a single cleavage
of the polynucleotide causes inactivation. On the other hand, the effects of changing
the tertiary structure of the molecule are not in themselves inactivating. It appears,
then, that the biological activity and genetic specificity are determined solely by the
complete sequence of most or all of the 6600 nucleotides within the RNA.
The effects of mutagenic agents upon the viral RNA are helping to clarify the
genetic role of the sequence of the nucleotides. The agent most commonly em-
ployed is nitrous acid, first shown by Schuster and Schramm to have a mutagenic
effect on the RNA from TMV. The chemical action of nitrous acid is known to be
the conversion of 3 of the 4 bases of RNA to bases which are similar except for
deaminations. One reaction converts cytosine to uracil, both naturally-existing bases.
The other 2 reactions convert adenine into hypoxanthine (a close analog of gua-
nine) and guanine into xanthine. The naturally-occurring uracil base is not affected
by nitrous acid treatment. The 3 reactions occur at comparable rates and do not
cause breakage of the polynucleotide strand. The deamination reaction causes in-
activation of the RNA at an exponential rate, indicating that the deamination of a
single base can be lethal to the whole RNA polymer. Chemical data correlated with
infectivity assay indicate that about 1 in 2 deaminations is, in fact, lethal. The ques-
tion, then, is whether or not some of the non-lethal deaminations are mutagenic.
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Mutants of tobacco mosaic virus can be detected by the symptomology of lesion
production and systemic disease, a particularly suitable plant for the study of le-
sions being Java tobacco. On this plant wild TMV produces diffuse, light chlorotic
lesions, whereas RNA which has been treated with nitrous acid will give rise to
local necrotic lesions. At low concentration of either virus or RNA the number of
lesions is closely proportional to the concentration of the inoculum. With this system
for assay Gierer and Mundry have studied in detail the mutagenic action of nitrous
acid. Infection with RNA from wild-type TMV yields only about 2 necrotic lesions
in 1,000 normal ones, whereas treatment of the virus or of its RNA with nitrous
acid results in the production of at least 30 per cent of such necrotic lesions. When
nitrous acid is used for a time such that its inactivating effect is small, one finds a
linear increase in the number of necrotic lesions with time of treatment. When
total infectivity is reduced by only a factor of 2, the number of necrotic lesions
reaches 20 times its spontaneous level. The kinetics of the relation of the produc-
tion of mutant symptoms with the degree of inactivation of the RNA constitute
proof that mutants have been produced by the chemical action of the nitrous acid.
There is always the certainty that some of the mutants, observed following treatment,
have arisen spontaneously and/or have pre-existed in the RNA inoculum. While
their quantitative effect cannot be large, there is always the chance that a particular
mutant isolated after nitrous acid treatment will not be a chemically-evoked one.
The kinetics of the production of mutants is first-order. In particular, the linear
increase of the production of mutants at the beginning of the reaction shows that
the deamination of a single nucleotide can be mutagenic. If it is assumed that the
efficiency of "plating" is not changed following mutation, the application of target
theory to the deamination reaction indicates that there are about 200 nucleotides in
the RNA molecule, the deamination of any one of which will lead to a necrotic-
lesion mutant. But other symptoms consequent upon mutation have been found,
such as host-symptom mutants, and if one includes all the expressions of mutation,
it appears that the deamination of any one of about 1000 nucleotides can lead to a
mutation.
To summarize the information on target sizes of RNA from TMV: the infecting
unit is the entire molecule, i.e., the target size from ribonuclease action is about
6000 nucleotides. This is the same order of size as has been found from radiation in-
activation, shown by Lauffer for intact TMV and by Ginoza for its RNA. The target
size for inactivation by deamination is about 2000 nucleotides, as shown by Schuster
and Schramm. The target size of all deanination mutants, detectable by host symp-
toms, is about 1000 nucleotides, of which about 200 are accounted for by necrotic
lesions.
It is not known which types of deamination are lethal and which are mutagenic.
The conversion of cytosine to uracil can be mutagenic, and probably conversion of
adenine to hypoxanthine (analogous to guanine) can result in mutation. Vielmetter
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and Schuster have shown that guanine deaminations are lethal in bacteriophage
DNA. If all the guanine deaminations are lethal in the RNA from TMV, it can be
calculated that most of the deaminations of adenine and cytosine will produce viable
mutants. But if the deamination of guanine in RNA does not inactivate it, then it
would turn out that most of the deaminations of adenine and cytosine are lethal
rather than solely mutagenic. Unfortunately it is not known which fraction of base
conversions leads to viable mutants and which fraction results in lethality. Both con-
sequences of base conversion seem to be about the same order of size and both
together account for most of the nucleotides in the RNA molecule.
What are the chemical consequences of the deamination reaction upon the viral
protein found in the progeny generations? Wittmann has analyzed the amino acid
composition of the viral protein resulting from mutation by nitrous acid, following
reaction conditions that have produced about 10 deaminations per RNA molecule.
In many cases it is found that the amino acid composition of the protein of the
mutant was like that of the wild-type virus; in about one-third of the cases there was
a change. With only one exception the change in amino acid composition was that
of the substitution of a single amino acid by another. Such substitution may appar-
ently take place anywhere along the complete peptide chain of the protein. These re-
sults lead to interesting consequences. First, it appears that the RNA is poly-func-
tional, in that part of it appears to have the role of a genetic determinant of protein
structure whereas other parts appear to have other, but unknown, functions. Second,
the deamination of a single nucleotide appears to result in the substitution of only
one amino acid by another (the one case observed of 2 substitutions can be ac-
counted for by 2 independent deaminations). This one-to-one relation between single
nucleotide deamination and single amino acid substitution is a proof of the postulate
of non-overlapping coding schemes, i.e., each amino acid in the protein is deter-
mined by an independent group of nucleotides. The target size for any amino acid
substitution does not exceed a few nucleotides per amino acid.
The study of effects of specific mutagens, like nitrous acid, is important in finding
the coding relation between nucleotide sequence and amino acid sequence. Any
hypothesis of coding leads to specific predictions as to which transitions of one
amino acid into another can be secured by deamination of a single nucleotide. So
far the pattern of changes does not allow the code to be revealed but it does aid in
rendering various coding schemes untenable. At present the work with TMV RNA
shows compatibility with a triplet code, degenerate or not. It should be emphasized
that this approach to the coding problem does not require the use of either se-
quential analysis of nucleotides nor of genetic mapping.
There are great difficulties encountered in investigating where and how the chemi-
cal structures of TMV are produced and assembled in the host cell. Only about one
virus particle in a million initiates an infection, it is not possible to infect many cells
simultaneously, and the infection spreads by unknown mechanisms from one cell
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to the next. But much work has been done on the mechanism of infection, and it
is in order to mention some of it which has direct relevance to virus replication.
Zech has studied what happens after individual hair cells have been inoculated with
TMV. He has found that a few hours following inoculation, but long before intact
TMV is detectable, large amounts of nucleic acid are produced in the nucleus (ob-
servable by ultraviolet microscopy). Later an excess of RNA appears in the cyto-
plasm, apparently at the expense of that in the nucleus. Many hours later, intact
virus begins to appear. At this time fibrous structures suspectible to digestion by
RNAse can be seen in the electron microscope. Zech's findings show that the pro-
duction of large amounts of RNA is among the first consequences of infection.
Whether this material is a precursor of viral RNA, or whether it is the viral RNA it-
self, is not known. Engler and Schramm have shown that at early stages of infection
much more infective RNA may be obtained, by phenol extraction, from the plant
tissue than is contained in the intactTMV that is present.
At the more chemical level, Davern and Bonner have reported that 5-fluorouracil,
which inhibits DNA synthesis, does not inhibit viral multiplication, thus indicating
that the synthesis of viral RNA does not depend on the production of complementary
DNA molecules. Staehelin has shown, by pulse-labelling of p32 , that RNA is as-
sembled from 5', rather than 3', nucleotides. Cleavage of the RNA into 5' nucleo-
tides leads to excessive labelling of adenine, while cleavage into 3' nucleotides leads
to equal labelling of all bases. The unequal labelling must be due to pool effects of
the RNA precursors. It follows that 5' nucleotides are precursors of RNA synthe-
sis, a result similar to the conclusions drawn from the in vitro enzymatic synthesis of
nucleic acids, both RNA and DNA.
In summary, it appears that all results on TMV are confirmatory of what is ex-
pected from our current ideas on the role of nucleic acid. Many of these experimental
confirmations were obtained first with TMV and later generalized to other systems.
The basic structure of small viruses (composed of one molecule of nucleic acid and
many equivalent protein sub-units), the infectivity of isolated RNA, the evidence in
favor of a single-stranded RNA, and the chemical mutation of the isolated genetic
material, were all originally discovered in work with TMV and subsequently con-
firmed for other RNA-containing viruses. At present TMV seems to provide the
best system for the study of the chemical effect of mutation on protein structure.
It is well in closing to bring up a few of the principal unsolved problems relating
to the function of RNA in the mechanism of infection. Is there a negative template
involved in the replication of viral RNA, and if so, is it cellular RNA? Does viral
RNA multiply autonomously in the cell without interaction with the chromosomes?
Certainly the large target size for mutation suggests autonomous replication of RNA.
Does some cellular RNA also self-multiply? What is the reason for the size of viral
RNA, of molecular weight about 2 million, which is universally found? It was shown
in Tiibingen some years ago that most of the cellular RNA is composed of single-
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stranded molecules and that the molecular weight of a large part of the microsomal
RNA in plant and animal tissues is about 2 million. Is there a relation in size, and
in the mechanism of production, of the cellular RNA to the viral RNA? What is
the function of those large portions of the RNA of TMV which are apparently not
related to the determination of the structure of the protein of the virus, but which
are still absolutely necessary for infection? Following inoculation are there early
proteins, enzymes, and other substances interacting with the constituents of the host
cell before the whole virus is assembled? What is the messenger carrying the genetic
information of the viral RNA to the site of protein synthesis? Is the viral RNA itself
the messenger, or a sub-unit of it? These are just a few of the questions arising from
the state of our current knowledge and ideas on the relation of cells to viruses. The
answers to some of them may come from further study of tobacco mosaic virus.
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